+

WO1996003150B1 - Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders - Google Patents

Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders

Info

Publication number
WO1996003150B1
WO1996003150B1 PCT/US1995/009230 US9509230W WO9603150B1 WO 1996003150 B1 WO1996003150 B1 WO 1996003150B1 US 9509230 W US9509230 W US 9509230W WO 9603150 B1 WO9603150 B1 WO 9603150B1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
dietary fiber
food
polyphenol
group
Prior art date
Application number
PCT/US1995/009230
Other languages
French (fr)
Other versions
WO1996003150A1 (en
Filing date
Publication date
Application filed filed Critical
Priority to DE69533593T priority Critical patent/DE69533593T2/en
Priority to EP95927341A priority patent/EP0797451B1/en
Priority to AT95927341T priority patent/ATE277638T1/en
Publication of WO1996003150A1 publication Critical patent/WO1996003150A1/en
Publication of WO1996003150B1 publication Critical patent/WO1996003150B1/en

Links

Abstract

Compositions containing hemicelluloses in combination with polyphenols, methods of preparing the compositions, and methods of treating humans or animals with the composition are provided. Also provided is a method for increasing growth rate, improving feed efficiency and decreasing scour after weaning in an animal by administering an effective amount of the composition to the animal. The hemicelluloses preferably are not consumed by human alimentary enzymes or harmful bacteria, such as putrefactive or pathogenic bacteria, in the gastrointestinal tract, and are consumed by beneficial bacteria, such as bifidobacteria, in the gastrointestinal tract. The polyphenols preferably decrease the amount of harmful bacteria in the gastrointestinal tract. The compositions can optionally contain a carrier or be used as a feed addition and are administered to humans or other animals in an amount sufficient to treat the gastrointestinal disorder.

Claims

AMENDED CLAIMS[received by the International Bureau on 18 March 1996 (18.03.96); original claims 1, 2, 4, 9, 10, 23 and 24 amended; new claims 36-43 added; remaining claims unchanged (4 pages)]
1. A composition comprising a dietary fiber which is water soluble, resists digestion by alimentary enzymes and is selectively digested by Bifidobactena and a polyphenol in an amount effective to alleviate gastrointestinal diseases caused by putrefactive or pathogenic bacteria in a human or other animal.
2. The composition of claim 1 wherein the dietary fiber is a hemicellulose and wherein the polyphenol contains at least three phenol moieties and has a molecular weight of between 280 and 6,000.
3. The composition of claim 2 wherein the hemicellulose is selected from the group consisting of arabinoxylan, galactomannan, arabinogalactan and wheat bran hemicellulose.
4. The composition of claim 1 wherein the dietary fiber is selected from the group consisting of inulin, fructose oligosaccharides, and transglycosylated oligosaccharides.
5. The composition of claim 1 wherein the polyphenol is a flavonoid.
6. The composition of claim 5 wherein the flavonoid is selected from the group consisting of tannins, taxifolins, catecholines, anthocyanins, and catechins.
7. The composition of claim 1 further comprising a pharmaceutically acceptable carrier for oral consumption.
8. The composition of claim 7 wherein the carrier is food.
9. A method for treating diseases in animals caused by putrefactive or pathogenic bacteria, the method comprising administering an effective amount of a composition comprising a dietary fiber which is water soluble, resists digestion by alimentary enzymes and is selectively digested by Bifidobactena, and a polyphenol to alleviate the disease in a human or other animal in need of treatment thereof.
10. The method of claim 9 wherein the dietary fiber is a hemicellulose and wherein the polyphenol contains at least three phenol moieties and has a molecular weight of between 280 and 6,000.
11. The method of claim 10 wherein the hemicellulose is selected from the group consisting of arabinoxylan, galactomannan, arabinogalactan and wheat bran hemicellulose.
12. The method of claim 9 wherein the dietary fiber is selected from the group consisting of inulin, fructose oligosaccharides and transglycosylated oligosaccharides.
13. The method of claim 9 wherein the polyphenol is a flavonoid.
14. The method of claim 13 wherein the flavonoid is selected from the group consisting of tannins, taxifolins, catecholines, anthocyanins and catechii-s.
15. The method of claim 9 wherein the composition is administered in a dosage of between 10 and 300 mg/kg body weight.
16. The method of claim 9 further comprising adding a carrier to the composition.
17. The method of claim 16 wherein the carrier is food.
18. The method of claim 17 wherein the composition is added to food in a concentration effective to increase the relative ratio of Bifidobactena to Clostridia.
19. The method of claim 17 wherein the composition is added to food in a concentration of between 0.1 and 5% by weight of the food.
20. The method of claim 17 wherein the composition is added to food in a concentration of between 0.1 and 2% by weight of the food.
21. The method of claim 9 wherein the animal is human.
22. The method of claim 21 wherein the animal is selected from the group consisting of poultry, swine, horses, calves, dogs and cats.
23. A method for increasing growth rate, improving feed efficiency and decreasing scour after weaning in an animal, the method comprising administering an effective amount of a composition comprising a dietary fiber, which is water soluble, resists digestion by animal alimentary enzymes, and is selectively digested by Bifidobactena, and a polyphenol to the animal.
24. The method of claim 23 wherein the dietary fiber is a hemicellulose and wherein the polyphenol contains at least three phenol moieties and has a molecular weight of between 280 and 6,000.
25. The method of claim 24 wherein the hemicellulose is selected from the group consisting of arabinoxylan, galactomannan, arabinogalactan and wheat bran hemicellulose.
26. The method of claim 23 wherein the dietary fiber is selected from the group consisting of inulin, fructose oligosaccharides and transglycosy lated oligosaccharides .
27. The method of claim 23 wherein the polyphenol is a flavonoid.
28. The method of claim 27 wherein the flavonoid is selected from the group consisting of tannins, taxifolins, catecholines, anthocyanins and catechins.
29. The method of claim 23 wherein the composition is administered in a dosage of between 10 and 300 mg/kg body weight.
30. The method of claim 23 further comprising adding a carrier to the composition.
31. The method of claim 30 wherein the carrier is food.
32. The method of claim 31 wherein the composition is added to food in a concentration effective to increase the relative ratio of bifidobactena to Clostridia.
33. The method of claim 32 wherein the composition is added to food in a concentration of between 0.1 and 5% by weight of the food.
34. The method of claim 32 wherein the composition is added to food in a concentration of between 0.1 and 2% by weight of the food.
35. The method of claim 35 wherein the animal is selected from the group consisting of poultry, swine, horses, calves, dogs and cats.
36. The composition of claim 3 wherein the dietary fiber is arabinogalactan.
37. The composition of claim 1 wherein the composition comprises a plant extract comprising the dietary fiber and the polyphenol.
38. The composition of claim 37 wherein the plant extract is derived from a tree of the genus Larix.
39. The composition of claim 38 wherein the dietary fiber is arabinogalactan.
40. The method of claim 9 or 23 wherein the dietary fiber is arabinogalactan.
41. The method of claim 9 or 23 wherein the method comprises administering to the animal a plant extract, wherein the plant extract comprises the dietary fiber and the polyphenol.
42. The method of claim 41 wherein the plant extract is derived from a tree of the genus Larix.
43. The method of claim 42 wherein the dietary fiber is arabinogalactan.
PCT/US1995/009230 1994-07-21 1995-07-21 Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders WO1996003150A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE69533593T DE69533593T2 (en) 1994-07-21 1995-07-21 PREPARATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDER CONTAINING ARABINOGALACTAN AND POLYPHENOLS OF LARIX.
EP95927341A EP0797451B1 (en) 1994-07-21 1995-07-21 Compositions containing arabinogalactan and polyphenols from larix for treating gastrointestinal disorders
AT95927341T ATE277638T1 (en) 1994-07-21 1995-07-21 PREPARATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS CONTAINING ARABINOGALACTAN AND POLYPHENOLS FROM LARIX.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27841494A 1994-07-21 1994-07-21
US278,414 1994-07-21

Publications (2)

Publication Number Publication Date
WO1996003150A1 WO1996003150A1 (en) 1996-02-08
WO1996003150B1 true WO1996003150B1 (en) 1996-05-02

Family

ID=23064883

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/009230 WO1996003150A1 (en) 1994-07-21 1995-07-21 Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders

Country Status (5)

Country Link
US (2) US5614501A (en)
EP (1) EP0797451B1 (en)
AT (1) ATE277638T1 (en)
DE (1) DE69533593T2 (en)
WO (1) WO1996003150A1 (en)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614501A (en) * 1994-07-21 1997-03-25 The University Of Montana Compositions and methods for animal husbandry and for treating gastrointestinal disorders
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US6071480A (en) * 1994-12-22 2000-06-06 Abbott Laboratories Method for generating a standing sonic wave, methods of sonication with a standing sonic wave, and a standing sonic wave sonicator
EP2179726A3 (en) * 1995-12-26 2012-09-26 Block Drug Company, Inc. Dietary fiber inulin delivery system
US6297273B1 (en) 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
US5965175A (en) * 1997-03-27 1999-10-12 The Iams Company Composition and method for repartitioning nitrogen and increasing colonic blood flow in dogs to promote intestinal health
FI107014B (en) * 1997-07-25 2001-05-31 Oriola Oy herbal remedies
AU9578898A (en) 1997-09-24 1999-04-12 Geoffrey N Richards Composition and method for reducing pathogenic bacteria in food products
US6039952A (en) * 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
DK172775B1 (en) * 1998-03-12 1999-07-12 Diarex V G Andresen Animal feed additives containing a flavanoid-containing mimosa extract and animal feed containing the same and method t
EP1076547A4 (en) 1998-04-27 2001-09-26 Larex Inc Derivatives of arabinogalactan and compositions including the same
EP1094722A1 (en) * 1999-04-27 2001-05-02 Diomeda Antonio Tortora Nutraceuticals and ingredients for functional foods
FR2801791B1 (en) * 1999-12-03 2003-05-30 Elpronat COMPOSITION FOR ANIMALS CONTAINING METHYL SALICYLATE
US6703056B2 (en) 2000-09-29 2004-03-09 The Procter + Gamble Co. Beverage compositions comprising arabinogalactan and defined minerals
US6706295B2 (en) 2000-09-29 2004-03-16 The Procter & Gamble Co. Compositions comprising arabinogalactan and a defined protein component
US20020110632A1 (en) * 2000-09-29 2002-08-15 The Procter & Gamble Co. Beverage compositions comprising arabinogalactan and defined vitamins
MXPA03008145A (en) * 2001-03-09 2003-12-12 Land O Lakes Farmland Feed Llc Method of feeding a ruminant.
US6365152B1 (en) 2001-03-15 2002-04-02 Bovine Health Products, Inc. Scours treatment and method of making same
ES2253555T5 (en) * 2001-08-20 2019-04-02 Cargill Inc Non-starch polysaccharides
WO2004017979A2 (en) * 2002-08-16 2004-03-04 Finzelberg Gmbh & Co. Kg Medicament, food supplement, and fodder additive
US7252836B2 (en) * 2003-01-13 2007-08-07 Penwest, Ltd. Food and feed compositions including resistant starch
US6936598B2 (en) * 2003-11-21 2005-08-30 Hill's Pet Nutrition, Inc. Composition and method
EP1695713A4 (en) * 2003-12-12 2009-06-24 Taiyo Kagaku Kk Enteropathy ameliorating composition
DE602004027120D1 (en) * 2004-05-25 2010-06-24 Cognis Ip Man Gmbh Oral and / or topical preparations
BRPI0418986A (en) * 2004-08-05 2007-12-11 Anidral Srl folic acid producing bifidobacterium bacterial strains, formulations and their uses
EP1869161B1 (en) * 2005-10-11 2010-01-06 Probiotical S.p.a. Method for the preparation of anallergic probiotic bacterial cultures and related use
KR100710657B1 (en) 2005-11-24 2007-04-24 코스맥스 주식회사 Whitening cosmetic composition containing dihydroquecetin
EP2012596A1 (en) * 2006-05-03 2009-01-14 Anidral S.R.L. Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses
US9420807B2 (en) * 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
GB0718974D0 (en) 2007-09-28 2007-11-07 Univ Leuven Kath oligosaccharides derived from arabinoxylan for prevention of gastrointestinal infection
CA2747569A1 (en) * 2007-12-21 2009-07-02 University Of Graz Use larch wood material for treating inflammation
US8734867B2 (en) * 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
JP5490020B2 (en) * 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
GB0805360D0 (en) * 2008-03-25 2008-04-30 Univ Leuven Kath Arabinoxylan oligosaccharide preparation
BRPI0913441A8 (en) 2008-06-09 2017-10-03 Temple Inland PREBIOTICS COMPOSITION AND METHODS OF PRODUCTION AND USE OF THE SAME
CN102421891B (en) 2009-03-04 2015-11-25 生命之叶公司 For method and the material of the site activation complexing of biomolecules
US8784844B2 (en) 2009-09-30 2014-07-22 Lonza Ltd. Arabinogalactan for enhancing the adaptive immune response
FI20096137A0 (en) * 2009-11-04 2009-11-04 Upm Kymmene Corp METHOD OF INFLUENCING THE MICROBIOTAN IN THE ANIMAL DIGESTION CHANNEL, FEED COMPOSITION CONTAINING THE MICROBIC MODULATOR AND THE USE OF THE MICROBIC MODULATOR
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
US9408880B2 (en) 2013-12-20 2016-08-09 Katherine Rose Kovarik Method and system for prevention and treatment of allergic and inflammatory diseases
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
EP2509453A4 (en) * 2009-12-08 2013-11-20 Tin Inc D B A Temple Inland Nutritional composition and methods of making and using same
US20110214318A1 (en) * 2010-03-05 2011-09-08 Sony Ericsson Mobile Communications Ab Paper Stock Card with Wireless Communication Capability
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
US20130236529A1 (en) * 2012-03-09 2013-09-12 Flavitpure, Inc. Composition and methods to enhance anti-oxidation, gut flora and immunity in pets
EP2638914A1 (en) * 2012-03-16 2013-09-18 Lonza Ltd Composition comprising arabinogalactan and polyphenols from larch trees
US8710027B2 (en) * 2012-04-10 2014-04-29 Flavitpure, Inc. Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia
US20130287919A1 (en) * 2012-04-26 2013-10-31 Flavitpure, Inc. Method of using dietary ingredients dihydroquercetin (taxifolin), arabinogalactan and arabinogalactan in combination with dihydroquercetin (taxifolin) for applications in food products
US20130331354A1 (en) * 2012-06-07 2013-12-12 Flavitpure, Inc. Method and composition utilizing larch wood extracts in animal feed
RU2504386C1 (en) * 2012-12-18 2014-01-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Preparation for prevention of diarrhoea in newborn calves
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
US9393259B2 (en) * 2013-03-21 2016-07-19 Lonza Ltd. Composition comprising arabinogalactan and polyphenols from larch trees
US10994013B2 (en) 2013-04-24 2021-05-04 Temple University—Of the Commonwealth System of Higher Education Solid dosage form containing arabinogalactan
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
CN107404902A (en) 2015-02-13 2017-11-28 马斯公司 Pet food feeds system
US20210038664A1 (en) * 2018-02-09 2021-02-11 Atp Institute Pty Ltd Formulation and method of use
WO2021173814A1 (en) * 2020-02-26 2021-09-02 Ralco Nutrition, Inc. Compositions based on dietary fibers and essential oils

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337526A (en) * 1965-10-15 1967-08-22 St Regis Paper Co Process for preparing arabinogalactan
SE446940B (en) * 1983-02-16 1986-10-20 Carl Axel Virdalm MEASURES FOR FIGHTING DISEASE CONDITIONS IN THE FOOD MELTER CONTAINING SHALL OR OUTSIDE OF BEERS OR FRUITS
SE8304821L (en) * 1983-09-08 1985-03-09 Bio Carb Ab ARABINOGALACTANTS, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
DK454683D0 (en) * 1983-10-03 1983-10-03 Mogens Gjerloev GAS ADMINISTRATIVE FOR TREATMENT OF ANIMALS AND USE OF ANIMALS
DE3564370D1 (en) * 1985-08-30 1988-09-22 Nestle Sa Dietetic product with depurating and antidiarrheal activity and process for its preparation
DE3622896A1 (en) * 1986-07-08 1988-01-21 Klaus Dr Laemmerhirt Compound of tannin and crosslinked polyvinylpyrrolidone for the treatment of diarrhoeal disorders and wounds
US4927811A (en) * 1988-11-15 1990-05-22 Coors Biotech, Inc. Method and composition for improved animal husbandry
GB8923890D0 (en) * 1989-10-24 1989-12-13 Rowett Research Services Limit Dietary material
US5294458A (en) * 1992-04-03 1994-03-15 Maruha Corporation Pet food
JPH06219953A (en) * 1993-01-27 1994-08-09 Ajinomoto Co Inc Medicine for preventing and improving diarrhea, food for preventing and improving diarrhea and feed for preventing and improving scours
US5439893A (en) * 1993-05-26 1995-08-08 University Of Montana Methods for the treatment and prevention of diarrhea
US5614501A (en) * 1994-07-21 1997-03-25 The University Of Montana Compositions and methods for animal husbandry and for treating gastrointestinal disorders
US5882520A (en) * 1995-10-26 1999-03-16 The University Of Montana Use of arabinogalactan in aqueous two phase extractions

Similar Documents

Publication Publication Date Title
WO1996003150B1 (en) Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders
US6087092A (en) Compositions and methods for animal husbandry and for treating gastrointestinal disorders
US10780137B2 (en) Composition to improve gut health and animal performance and methods of making the same
JPH0256062B2 (en)
Wallace et al. Microbial feed additives for ruminants
EA017656B1 (en) Composition for prevention and treatment of pig dysentery
US5112624A (en) Prevention of digestive disturbances in herbivores
JP2015521052A (en) Methods and compositions utilizing larch wood extract in animal feed
WO1995017103A1 (en) The use of mannan-rich materials in feedstuffs
KR20000052237A (en) A method of manufacturing a feed composite ,which contains yellow earth and chitosan, for livestock and cultured fish
IE53057B1 (en) Lactation improvement method
Tabeling et al. Studies on nutrient digestibilities (pre‐caecal and total) in pancreatic duct‐ligated pigs and the effects of enzyme substitution
AU732890B2 (en) Method for improving the efficacy of a probiotic, preparation of nutritional additives, and animal feed containing it
EP1083800A1 (en) Piglet feeding method
CN114831248B (en) Biological mildew removing agent and preparation method and application thereof
AU2003204441A1 (en) Animal Food Supplement Compositions and Methods of Use
KR20010068226A (en) composition containing chitosan oligo saccharide and aminoethyl sulfonic acid for use as fodder and drinking water additives
Hampson et al. Pre-weaning supplementary feed and porcine post-weaning diarrhoea
JPH06256180A (en) Enteric environment-improving composition
EP1605776B1 (en) Method and composition for preventing or reducing diarrhea
JP3257690B2 (en) Feed for livestock with dietary fiber
CN105454695A (en) Feed additive for preventing and curing porcine diarrhea
US20170014443A1 (en) Compositions and methods for treating gastrointestinal disorders for humans and animal husbandry
KR100892050B1 (en) Weaned pig feed additive composition containing beta glucan and yeast organic iron
JPH1189512A (en) Health hood
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载